Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Saniona AB
DescriptionSelective GABA A alpha 2,3 (positive) (allosteric) modulator
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsNeuropathic pain
Regulatory Designation
PartnerBiocon Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today